| Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas JG Cairncross, K Ueki, MC Zlatescu, DK Lisle, DM Finkelstein, ... JNCI: Journal of the National Cancer Institute 90 (19), 1473-1479, 1998 | 1959 | 1998 |
| Breast cancer in China L Fan, K Strasser-Weippl, JJ Li, J St Louis, DM Finkelstein, KD Yu, ... The lancet oncology 15 (7), e279-e289, 2014 | 1891 | 2014 |
| Regression of microalbuminuria in type 1 diabetes BA Perkins, LH Ficociello, KH Silva, DM Finkelstein, JH Warram, ... New England Journal of Medicine 348 (23), 2285-2293, 2003 | 1091 | 2003 |
| Correcting for noncompliance and dependent censoring in an AIDS clinical trial with inverse probability of censoring weighted (IPCW) log‐rank tests JM Robins, DM Finkelstein Biometrics 56 (3), 779-788, 2000 | 1024 | 2000 |
| A proportional hazards model for interval-censored failure time data DM Finkelstein Biometrics, 845-854, 1986 | 945 | 1986 |
| Parental involvement in diabetes management tasks: relationships to blood glucose monitoring adherence and metabolic control in young adolescents with insulin-dependent … B Anderson, J Ho, J Brackett, D Finkelstein, L Laffel The Journal of pediatrics 130 (2), 257-265, 1997 | 794 | 1997 |
| Planning cancer control in Latin America and the Caribbean PE Goss, BL Lee, T Badovinac-Crnjevic, K Strasser-Weippl, ... The lancet oncology 14 (5), 391-436, 2013 | 704 | 2013 |
| Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma CR Ferrone, DM Finkelstein, SP Thayer, A Muzikansky, CF Castillo, ... Journal of clinical oncology 24 (18), 2897-2902, 2006 | 666 | 2006 |
| Out-of-hospital cardiac arrest DJ Wilber, H Garan, D Finkelstein, E Kelly, J Newell, B McGovern, ... New England Journal of Medicine 318 (1), 19-24, 1988 | 572 | 1988 |
| Germ-Line BRCA1 Mutations in Jewish and Non-Jewish Women with Early-Onset Breast Cancer MG FitzGerald, DJ MacDonald, M Krainer, I Hoover, E O'Neil, H Unsal, ... New England Journal of Medicine 334 (3), 143-149, 1996 | 517 | 1996 |
| TBCRC009: a multicenter phase II clinical trial of platinum monotherapy with biomarker assessment in metastatic triple-negative breast cancer SJ Isakoff, EL Mayer, L He, TA Traina, LA Carey, KJ Krag, HS Rugo, ... Journal of clinical oncology 33 (17), 1902-1909, 2015 | 513 | 2015 |
| Quantitatively determined survivin expression levels are of prognostic value in human gliomas A Chakravarti, E Noll, PML Black, DF Finkelstein, DM Finkelstein, ... Journal of Clinical Oncology 20 (4), 1063-1068, 2002 | 513 | 2002 |
| Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study. DM Finkelstein, DS Ettinger, JC Ruckdeschel Journal of Clinical Oncology 4 (5), 702-709, 1986 | 461 | 1986 |
| A Controlled Trial of Trimethoprim–Sulfamethoxazole or Aerosolized Pentamidine for Secondary Prophylaxis of Pneumocystis carinii Pneumonia in Patients with … WD Hardy, J Feinberg, DM Finkelstein, ME Power, W He, C Kaczka, ... New England journal of medicine 327 (26), 1842-1848, 1992 | 453 | 1992 |
| Characterization of BRCA1 and BRCA2 Mutations in a Large United States Sample S Chen, ES Iversen, T Friebel, D Finkelstein, BL Weber, A Eisen, ... Journal of Clinical Oncology 24 (6), 863-871, 2006 | 450 | 2006 |
| Heterozygous ATM mutations do not contribute to early onset of breast cancer MG Fitzgerald, JM Bean, SR Hegde, H Unsal, DJ Macdonald, DP Harkin, ... Nature genetics 15 (3), 307-310, 1997 | 440 | 1997 |
| Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group. PD Bonomi, DM Finkelstein, JC Ruckdeschel, RH Blum, MD Green, ... Journal of Clinical Oncology 7 (11), 1602-1613, 1989 | 432 | 1989 |
| Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group. SA Grossman, DM Finkelstein, JC Ruckdeschel, DL Trump, T Moynihan, ... Journal of clinical oncology 11 (3), 561-569, 1993 | 429 | 1993 |
| Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses K Ikeda, T Ichikawa, H Wakimoto, JS Silver, TS Deisboeck, D Finkelstein, ... Nature medicine 5 (8), 881-887, 1999 | 414 | 1999 |
| A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer. JC Ruckdeschel, DM Finkelstein, DS Ettinger, RH Creech, BA Mason, ... Journal of Clinical Oncology 4 (1), 14-22, 1986 | 414 | 1986 |
